Keratoconus Detection by Ultrasound

Sponsor
Columbia University (Other)
Overall Status
Completed
CT.gov ID
NCT01403129
Collaborator
National Eye Institute (NEI) (NIH)
250
2
109
125
1.1

Study Details

Study Description

Brief Summary

Keratoconus (KC) is a corneal disease which will in many cases ultimately require corneal transplantation to maintain vision. Early detection, which is not possible with current technology, would allow early treatment and prevent severe damage to KC corneas inadvertently operated upon for correction of vision. The investigators' aim is to combine measurements of different properties of the cornea to develop means for early detection of KC.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Artemis Ultrasound Exam
  • Procedure: Optical Coherence Tomography (OCT) Exam

Detailed Description

Keratoconus is the most common degenerative disease affecting the cornea. As keratoconus develops, the cornea thins and bulges. Eventually, a corneal transplant may be needed to maintain vision. In its earliest stages, the disease is particularly difficult to detect. This is of great importance to the corneal refractive surgeon because surgical treatment of a keratoconic cornea will weaken it and greatly accelerate the occurrence of symptoms. Early detection of keratoconus will benefit patients because of the recent development of methods for strengthening the corneal stroma and preventing disease progression.

The investigators have developed a technique based on the use of high resolution ultrasound for imaging the cornea and measuring the thickness of its component layers, including the epithelium and the stroma. In early keratoconus, as the anterior stromal surface begins to bulge forward, the epithelium will thin above the apex of the bulge and thicken around it, to maintain a smooth anterior surface. The investigators have also developed methods for characterizing the elastic properties of the cornea by inducing and measuring surface displacements in response to a pulse of acoustic radiation force.

The investigators' goal is to reduce the percentage of screened cases deemed keratoconus-suspect by at least a factor of two by allowing an unambiguous diagnosis of early keratoconus. This would provide two major benefits; (1) to be able to predict eyes with higher risk of developing ectasia after corneal refractive surgery, and (2) early diagnosis would allow earlier treatment of the condition with collagen crosslinking, preserving the cornea from disease progression.

Study Design

Study Type:
Observational
Anticipated Enrollment :
250 participants
Observational Model:
Case-Control
Time Perspective:
Cross-Sectional
Official Title:
Early Detection of Keratoconus Using Ultrasound
Study Start Date :
Dec 1, 2010
Actual Primary Completion Date :
Jan 1, 2020
Actual Study Completion Date :
Jan 1, 2020

Arms and Interventions

Arm Intervention/Treatment
Keratoconus-Suspect

A person who has or is suspected of having keratoconus. Will have either or both Artemis-2 exam and OCT exam.

Procedure: Artemis Ultrasound Exam
Ultrasound exam of both eyes using an Artemis-2 device. Exam will be performed once. Exam duration is 20 minutes per eye.
Other Names:
  • Ultrasound biomicroscope (UBM)
  • High frequency ultrasound
  • Procedure: Optical Coherence Tomography (OCT) Exam
    OCT exam of both eyes. Exam will be performed once, duration is 10. I utes per eye.
    Other Names:
  • OCT
  • Keratoconus-Related

    A person who is genetically related to someone with keratoconus. Will have either or both Artemis-2 exam and OCT exam.

    Procedure: Artemis Ultrasound Exam
    Ultrasound exam of both eyes using an Artemis-2 device. Exam will be performed once. Exam duration is 20 minutes per eye.
    Other Names:
  • Ultrasound biomicroscope (UBM)
  • High frequency ultrasound
  • Procedure: Optical Coherence Tomography (OCT) Exam
    OCT exam of both eyes. Exam will be performed once, duration is 10. I utes per eye.
    Other Names:
  • OCT
  • Age-Matched Normal

    A person who is approximately the same age as subjects who have been enrolled in the study. Will have either or both Artemis-2 exam and OCT exam.

    Procedure: Artemis Ultrasound Exam
    Ultrasound exam of both eyes using an Artemis-2 device. Exam will be performed once. Exam duration is 20 minutes per eye.
    Other Names:
  • Ultrasound biomicroscope (UBM)
  • High frequency ultrasound
  • Procedure: Optical Coherence Tomography (OCT) Exam
    OCT exam of both eyes. Exam will be performed once, duration is 10. I utes per eye.
    Other Names:
  • OCT
  • Outcome Measures

    Primary Outcome Measures

    1. Differences in elastic parameters between normal and KC corneas. [Up to 1 year after enrollment]

      The undamped vibrational frequency and damping time-constant for the anterior and posterior corneal surfaces and for Bowman's membrane will be measured. The elastic modulus will be calculated form the change in corneal thickness resulting from known radiation force.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    6 Years to 65 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    • Clinical diagnosis of keratoconus (KC) or keratoconus-suspect

    • Blood relation of person with KC

    • Age-matched normal of KC subjects

    • Ability to sit still in front of ultrasound unit and lie on exam table

    Exclusion Criteria:
    • Other eye disease

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Columbia University Medical Center New York New York United States 10032
    2 London Vision Clinic London England United Kingdom W1G 7LA

    Sponsors and Collaborators

    • Columbia University
    • National Eye Institute (NEI)

    Investigators

    • Principal Investigator: Ronald H Silverman, PhD, Columbia University

    Study Documents (Full-Text)

    None provided.

    More Information

    Additional Information:

    Publications

    None provided.
    Responsible Party:
    Ronald H Silverman, Professor of Ophthalmic Science, Columbia University
    ClinicalTrials.gov Identifier:
    NCT01403129
    Other Study ID Numbers:
    • AAAF1497
    • R01EY019055
    First Posted:
    Jul 27, 2011
    Last Update Posted:
    Aug 3, 2021
    Last Verified:
    Aug 1, 2021
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Keywords provided by Ronald H Silverman, Professor of Ophthalmic Science, Columbia University
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Aug 3, 2021